Valuation: AcouSort AB

Market Cap 75.13M 7.75M 6.8M 6.33M 5.82M 10.92M 740M 11.11M 29.41M 367M 29.09M 28.46M 1.27B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 75.13M 7.75M 6.8M 6.33M 5.82M 10.92M 740M 11.11M 29.41M 367M 29.09M 28.46M 1.27B EV / Sales 2026 *
7.09x
EV / Sales 2027 * 5.08x
Free-Float
59.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.84%
1 week-3.01%
Current month-5.84%
1 month-11.25%
3 months-9.67%
6 months+35.50%
Current year+25.44%
1 week 3.3
Extreme 3.3
3.72
1 month 3.13
Extreme 3.13
4.1
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 01/01/2014
Director of Finance/CFO 65 01/01/2016
Director TitleAgeSince
Director/Board Member 64 01/01/2012
Chairman 65 01/01/2011
Director/Board Member - 01/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-3.01%-2.47%-76.17% 7.79M
+0.14%-0.67%-0.88%+11.02% 47.74B
-2.24%+0.31%+393.45%+615.13% 39.98B
+1.40%+3.69%+12.21%+46.79% 36.23B
+13.94%+20.49%+22.85%+7.42% 35.59B
-0.73%+3.38%+4.94%+41.45% 27.91B
+0.40%-0.30% - - 16.71B
-3.12%+7.39%+26.03%+124.08% 16.45B
+2.39%-1.64%+4.74%+9.95% 13.21B
+6.79%+8.17%-4.97%-28.52% 12.93B
Average +1.81%+2.64%+50.65%+83.46% 24.68B
Weighted average by Cap. +2.10%+2.54%+76.11%+130.58%

Financials

2026 *2027 *
Net sales 10.6M 1.09M 959K 893K 822K 1.54M 104M 1.57M 4.15M 51.8M 4.1M 4.02M 179M 14.8M 1.53M 1.34M 1.25M 1.15M 2.15M 146M 2.19M 5.79M 72.33M 5.73M 5.61M 250M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
28/07/26 SEK 3.550 -0.84% 10,204
27/07/26 SEK 3.580 -3.76% 11,776
24/07/26 SEK 3.720 +4.79% 5,945
23/07/26 SEK 3.550 -0.56% 11,375
22/07/26 SEK 3.570 -2.46% 42,937

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock